Endoscopes (Flexible/Rigid) in Colorado

Dragonfly Endoscopy Inc. is a medical device manufacturer specializing in advanced pancreaticobiliary endoscopy systems. The company's flagship product is the world's first and only 360° rotatable pancreaticobiliary scope, designed to improve diagnostic and therapeutic capabilities in cholangiopancreatoscopy procedures. The device features a 42% increase in working channel diameter compared to current standard endoscopes without increasing external scope dimensions, enabling a 50% larger biopsy cup and 2.4x larger electrohydraulic lithotripsy (EHL) probe diameter. The scope combines refined optics, precision control, and advanced therapeutic capabilities to address long-standing limitations in pancreaticobiliary care. Dragonfly received FDA 510(k) clearance in May 2024 and has completed initial clinical procedures at University of Colorado Anschutz Medical Campus. The company is led by experienced medtech executives with extensive backgrounds in gastrointestinal device development, commercialization, and market launches, including prior roles at Boston Scientific, Olympus, and successful exits of multiple venture-backed GI startups. The firm targets gastroenterologists and interventional endoscopists performing ERCP and related pancreaticobiliary procedures in hospital and ambulatory settings.

EvoEndo is a specialized medical device manufacturer focused on sedation-free endoscopy solutions for pediatric and adult gastroenterology. The company develops ultra-thin, single-use endoscopes designed for both transnasal and transoral procedures, eliminating the need for anesthesia while maintaining diagnostic and therapeutic capability. The EvoEndo System comprises ultra-slim flexible scopes with four-way steering, a portable high-definition controller, and virtual reality-based patient distraction technology. FDA-cleared for visualization and treatment of the upper digestive tract (esophagus, stomach, duodenal bulb), the system is available in 85 cm (pediatric) and 110 cm (adult/pediatric) configurations. By removing anesthesia and associated risks, the platform reduces procedure costs, recovery time, and complications—particularly beneficial for pediatric patients requiring multiple endoscopies. EvoEndo is recognized as the only medical device firm dedicated exclusively to pediatric gastroenterology care and aligns its innovations with current clinical guidelines.

Aspero Medical is a Boulder, Colorado-based medical device manufacturer specializing in innovative endoscopy technology for gastrointestinal (GI) procedures. Founded in 2018, the company develops patented balloon overtube systems designed to enhance diagnostic and interventional GI endoscopy. Their flagship Pillar™ technology features micro-textured balloon surfaces that improve mucosal wall traction and anchoring consistency in the GI tract, enabling deeper scope advancement and reducing procedure time. The Ancora-SB small bowel balloon overtube received FDA clearance in 2023. Aspero Medical's solutions address technical challenges in balloon endoscopy for small bowel disease diagnosis and treatment, enabling healthcare providers to complete complex procedures more efficiently on the first attempt while improving patient outcomes and lab throughput.